How Many Synergy Pharmaceuticals Inc (NASDAQ:SGYP)'s Analysts Are Bearish?

Author

06 June, 2017

Usually the RSI is considered overbought when above 70 and oversold when less than 30.

Other research analysts have also issued research reports about the company. Guggenheim reaffirmed an "outperform" rating and set a $10.00 price target on shares of Synergy Pharmaceuticals in a research report on Thursday, March 2nd. Similarly, the company's last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry's and sector's high P/E for the past year is 237.16 and 43.55 respectively and low P/E ratio for the last 5 years is 83.26 for the industry and 23.18 for the Sector. The stock of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) earned "Buy" rating by TH Capital on Thursday, October 29. HC Wainwright set a $18.00 target price on Synergy Pharmaceuticals and gave the company a "buy" rating in a report on Friday, January 27th. Synergy Pharmaceuticals presently has an average rating of "Buy" and an average price target of $11.50.

05/15/2017 - Synergy Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at Rodman & Renshaw. A rating of 3 would signify a consensus Hold recommendation.

Williams Jones And Associate Ltd Limited Liability Company owns 0% invested in Synergy Pharmaceuticals Inc (NASDAQ:SGYP) for 11,000 shares. The firm's market capitalization is $913.29 million. Synergy Pharmaceuticals has a one year low of $3.34 and a one year high of $7.15. The share price has moved backward from its 20 days moving average -2.26% and negatively from its 50 days moving average -9.99%.

Over the last 5 years, Synergy Pharmaceuticals Inc. has averaged a -31.80% YoY EPS growth rate. The biopharmaceutical company reported ($0.30) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.23) by $0.07. The business had revenue of $0.10 million for the quarter, compared to analysts' expectations of $0.10 million. On average, equities analysts expect that Synergy Pharmaceuticals will post ($0.91) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & worldwide copyright and trademark law.

Synergy Pharmaceuticals, Inc. (SGYP) has been given an average price target of $10.44 from analysts, according to data collected by Finviz. The company's stock had a trading volume of 18,455,490 shares. State Street Corp boosted its position in shares of Synergy Pharmaceuticals by 11.6% in the fourth quarter. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Asymmetry Capital Management L.P. now owns 339,068 shares of the biopharmaceutical company's stock valued at $1,868,000 after buying an additional 40,878 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in Synergy Pharmaceuticals by 32.5% in the third quarter. State Street Corp now owns 6,283,669 shares of the biopharmaceutical company's stock valued at $38,270,000 after buying an additional 653,353 shares in the last quarter. Swiss National Bank boosted its stake in Synergy Pharmaceuticals by 67.8% in the third quarter. Pacad Investment Ltd. now owns 217,283 shares of the biopharmaceutical company's stock worth $1,323,000 after buying an additional 189,183 shares during the last quarter. Paulson & CO. Inc. purchased a new stake in shares of Synergy Pharmaceuticals during the fourth quarter valued at about $146,700,000.

Large investors have recently modified their holdings of the company. The legal version of this story can be viewed at https://www.themarketsdaily.com/2017/06/06/2-82-million-in-sales-expected-for-synergy-pharmaceuticals-inc-sgyp-this-quarter.html. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide.


More news


  • Ryon Healy homers twice for 5 RBIs, A's beat Blue Jays

    Ryon Healy homers twice for 5 RBIs, A's beat Blue Jays

    Toronto cut the deficit to 5-2 in the fifth as Ezequiel Carrera led off with a walk and scored on Pillar's double to left. Justin Smoak hit his 15th home run in the eighth off Liam Hendriks for the Blue Jays, who couldn't do enough for J.A.
    Cleveland Police Officer Who Fatally Shot Tamir Rice Is Fired

    Cleveland Police Officer Who Fatally Shot Tamir Rice Is Fired

    Rice had been playing with what looked like a gun in a park near his home when someone called 911 to report him. The investigation deduced that the dispatcher had violated standard protocol in the way she handled the call.
    Fatal Australian siege called terror attack

    Fatal Australian siege called terror attack

    Khayre was one of five men tried as part of an alleged 2009 terrorist "plot" against the Holsworthy army base in Sydney . Prime Minister Turnbull described the attack as "shocking" and a "cowardly crime". "He had a long record of violence".
  • London Bridge attacker known to security services as two terrorists named

    London Bridge attacker known to security services as two terrorists named

    Local newspapers said the man lived in London and worked in Boro Bistro, a Breton-run restaurant in Borough Market. Police received reports of a van speeding into pedestrians on London Bridge at 10:08pm (2108 GMT).

    Warriors Pound Cavaliers Again for 2-0 Finals Lead

    This was not a flawless game for them by any stretch and it was still more than enough to overcome James at near his best. There is room for improvement, and the Cavs believe they can make the adjustments that lead to that improvement.
    Oppo R11 with 20MP front camera launched

    Oppo R11 with 20MP front camera launched

    The smartphone is powered by a 2,900 mAh battery which should also be able to last for a day's worth of usage easily. The power button is seen sitting on the right edge, while the volume button sits on the left edge of the Oppo R11.
  • Melbourne siege a terrorist incident

    They tried to negotiate with the man, identified as Yacqub Khayre , 29, but he walked out of the building firing a shotgun. A woman was held hostage by a suspect who was later shot dead by police in a volley of gunfire in the apartment block.
    Saudi Arabia, UAE, Egypt, Bahrain cut ties to Qatar

    Saudi Arabia, UAE, Egypt, Bahrain cut ties to Qatar

    Shares in Islamic Bank Masraf Al Rayan jumped 7.4 percent and Vodafone Qatar, the most heavily traded stock , gained 3.0 percent. This support, as even many western news reports on the Saudi-Qatari confrontation acknowledge, has "emboldened" Saudi Arabia.
    Amazon Prime Video Coming to Apple TV Later This Year

    Amazon Prime Video Coming to Apple TV Later This Year

    Other new watchfaces include a kaleidoscope and new characters such as Woody, Jesse, and Buzz from the Toy Story movie franchise. All in all, it was a big day for Apple, with more big news expected tomorrow, on Day 2 of the worldwide developers conference .
  • Apple expected to launch smart speaker

    Apple expected to launch smart speaker

    The watch can communicate with some gym equipment to share data between the two - like your heart rate or the treadmill's incline. Emojis won't be the only features iPhone 5 users are missing out on if Apple fails to release an iOS 11 update for the device.
    Everything You Need To Know About Apple's New Products

    Everything You Need To Know About Apple's New Products

    The update will now automatically display the information most important to you, there is even a cool new "kalidescope page". Apple also talked about an app Ikea is making to help people visualize furniture in their homes before they buy it.
    Apple just jumped head-first into augmented reality

    Apple just jumped head-first into augmented reality

    Apple announced this subtle change to the system settings at its Worldwide Developers Conference (WWDC) in San Jose on Monday. It wouldn't be the first time that Apple hopped on the bandwagon of a technology product popularized by a competitor.